A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Atevirdine mesylate

DRUG

Zidovudine

Trial Locations (12)

19107

Buckley Braffman Stern Med Associates, Philadelphia

33614

Infectious Disease Research Institute Inc, Tampa

53202

Wisconsin Community - Based Research Consortium, Milwaukee

77004

Park Plaza Hosp, Houston

78284

Univ TX San Antonio Health Science Ctr, San Antonio

90033

Los Angeles County / Health Research Assoc / Drew Med Ctr, Los Angeles

92668

UCI Med Ctr, Orange

94114

Davies Med Ctr, San Francisco

212052196

Johns Hopkins Hosp, Baltimore

02118

Boston City Hosp / FGH-1, Boston

07018

East Orange Veterans Administration Med Ctr, East Orange

02860

Mem Hosp of Rhode Island, Pawtucket

All Listed Sponsors
lead

Pharmacia and Upjohn

INDUSTRY

NCT00002322 - A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients | Biotech Hunter | Biotech Hunter